OR51B4
gene geneOn this page
Summary
OR51B4 (olfactory receptor family 51 subfamily B member 4, HGNC:14708) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 51B4 (Q9Y5P0). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 79339 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- MANE Select transcript:
NM_033179
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14708 |
| Approved symbol | OR51B4 |
| Name | olfactory receptor family 51 subfamily B member 4 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000183251 |
| Ensembl biotype | protein_coding |
| Entrez | 79339 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000380224
RefSeq mRNA: 1 — MANE Select: NM_033179
NM_033179
CCDS: CCDS7757
Canonical transcript exons
ENST00000380224 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001484148 | 5301014 | 5301946 |
Expression profiles
Bgee: expression breadth broad, 30 present calls, max score 56.41.
Top tissues by expression
197 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 56.41 | gold quality |
| skin of hip | UBERON:0001554 | 46.74 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| sural nerve | UBERON:0015488 | 43.12 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| right ovary | UBERON:0002118 | 40.54 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
| ovary | UBERON:0000992 | 40.19 | silver quality |
| jejunum | UBERON:0002115 | 40.18 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.06 | gold quality |
| oviduct epithelium | UBERON:0004804 | 40.03 | gold quality |
| mammary duct | UBERON:0001765 | 39.98 | gold quality |
| left ovary | UBERON:0002119 | 39.95 | silver quality |
| mucosa of sigmoid colon | UBERON:0004993 | 39.95 | gold quality |
| deltoid | UBERON:0001476 | 39.83 | gold quality |
| saphenous vein | UBERON:0007318 | 39.83 | gold quality |
| parotid gland | UBERON:0001831 | 39.81 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.31 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or51b4 | ENSMUSG00000058200 |
| rattus_norvegicus | Or51b4b | ENSRNOG00000025163 |
| rattus_norvegicus | Or51b4 | ENSRNOG00000069104 |
Paralogs (51): OR51E2 (ENSG00000167332), OR51B5 (ENSG00000167355), OR51I1 (ENSG00000167359), OR51Q1 (ENSG00000167360), OR52A5 (ENSG00000171944), OR52W1 (ENSG00000175485), OR51B6 (ENSG00000176239), OR51V1 (ENSG00000176742), OR52E2 (ENSG00000176787), OR51L1 (ENSG00000176798), OR51G2 (ENSG00000176893), OR51A7 (ENSG00000176895), OR51T1 (ENSG00000176900), OR51S1 (ENSG00000176922), OR51F2 (ENSG00000176925), OR51E1 (ENSG00000180785), OR56B4 (ENSG00000180919), OR52E4 (ENSG00000180974), OR52N2 (ENSG00000180988), OR52N1 (ENSG00000181001), OR52N5 (ENSG00000181009), OR56B2 (ENSG00000181017), OR56B1 (ENSG00000181023), OR52N4 (ENSG00000181074), OR52P1 (ENSG00000181109), OR52D1 (ENSG00000181609), OR52H1 (ENSG00000181616), OR52K2 (ENSG00000181963), OR52A1 (ENSG00000182070), OR52E8 (ENSG00000183269), OR52L1 (ENSG00000183313), OR51M1 (ENSG00000184698), OR52B6 (ENSG00000187747), OR51I2 (ENSG00000187918), OR52K1 (ENSG00000196778), OR51D1 (ENSG00000197428), OR51C1 (ENSG00000197674), OR52M1 (ENSG00000197790), OR52E6 (ENSG00000205409), OR52J3 (ENSG00000205495)
Protein
Protein identifiers
Olfactory receptor 51B4 — Q9Y5P0 (reviewed: Q9Y5P0)
Alternative names: Odorant receptor HOR5’beta1
All UniProt accessions (1): Q9Y5P0
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_149419* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (20 total): topological domain 8, transmembrane region 7, sequence variant 2, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y5P0-F1 | 88.27 | 0.58 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 95–186
Glycosylation sites (1): 4
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 37 (showing top):
GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, GOBP_RESPONSE_TO_LIPID, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP, GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_UP
GO Biological Process (6): sensory perception of smell (GO:0007608), cellular response to lipid (GO:0071396), system process (GO:0003008), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), signaling receptor activity (GO:0038023)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of chemical stimulus | 1 |
| response to lipid | 1 |
| cellular response to chemical stimulus | 1 |
| multicellular organismal process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| molecular transducer activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
326 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR51B4 | WFDC6 | Q9BQY6 | 396 |
| OR51B4 | A0A0J9YYA3 | A0A0J9YYA3 | 326 |
| OR51B4 | SSC4D | Q8WTU2 | 324 |
| OR51B4 | HBG1 | P02096 | 322 |
| OR51B4 | ZNF454 | Q8N9F8 | 308 |
| OR51B4 | ZNF540 | Q8NDQ6 | 301 |
| OR51B4 | EIF4E1B | A6NMX2 | 296 |
| OR51B4 | HYLS1 | Q96M11 | 295 |
| OR51B4 | KRTAP13-1 | Q8IUC0 | 294 |
| OR51B4 | ZNF791 | Q3KP31 | 290 |
| OR51B4 | HBB | P02023 | 281 |
| OR51B4 | TAS2R1 | Q9NYW7 | 281 |
| OR51B4 | MRPS11 | P82912 | 269 |
| OR51B4 | WFDC5 | Q8TCV5 | 265 |
| OR51B4 | KLK9 | Q9UKQ9 | 259 |
IntAct
0 interactions, top by confidence:
BioGRID (1): OR51B4 (Affinity Capture-MS)
ESM2 similar proteins: A0A3B3IT45, A6NGY5, O88628, P0C646, Q6IFG1, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGH6, Q8NGH7, Q8NGH9, Q8NGI0, Q8NGI2, Q8NGJ2, Q8NGJ3, Q8NGJ4, Q8NGJ5, Q8NGJ6, Q8NGJ7, Q8NGJ9, Q8NGK1, Q8NGK2, Q8NGK3, Q8NGK4, Q8NGK5, Q8NGK6, Q8NH53, Q8NH55, Q8NH56, Q8NH57, Q8NH59, Q8NH60, Q8NH61, Q8NH63, Q8NH64, Q8TCB6, Q8VBV9, Q96RD2, Q96RD3, Q9H255
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
213 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:5301682:C:CA | donor_gain | 0.7600 |
| 11:5301295:T:TC | acceptor_gain | 0.6900 |
| 11:5301288:T:C | acceptor_gain | 0.6500 |
| 11:5301300:A:C | acceptor_gain | 0.6500 |
| 11:5301614:G:C | donor_gain | 0.5900 |
| 11:5301615:ATAC:A | donor_loss | 0.5900 |
| 11:5301616:TACCT:T | donor_loss | 0.5900 |
| 11:5301617:AC:A | donor_loss | 0.5900 |
| 11:5301618:C:CC | donor_loss | 0.5900 |
| 11:5301298:G:C | acceptor_gain | 0.5800 |
| 11:5301300:A:AC | acceptor_gain | 0.5800 |
| 11:5301619:C:G | donor_loss | 0.5700 |
| 11:5301736:T:TA | donor_gain | 0.5700 |
| 11:5301298:G:GC | acceptor_gain | 0.5600 |
| 11:5301772:A:AC | donor_gain | 0.5600 |
| 11:5301941:C:CT | donor_gain | 0.5500 |
| 11:5301448:CACAA:C | acceptor_gain | 0.5400 |
| 11:5301777:A:C | donor_gain | 0.5400 |
| 11:5301888:G:GA | donor_gain | 0.5200 |
| 11:5301288:T:TC | acceptor_gain | 0.5100 |
| 11:5301614:GATAC:G | donor_gain | 0.5100 |
| 11:5301325:CAT:C | acceptor_gain | 0.5000 |
| 11:5301302:A:C | acceptor_gain | 0.4900 |
| 11:5301328:C:CC | acceptor_gain | 0.4900 |
| 11:5301283:CTGT:C | acceptor_gain | 0.4800 |
| 11:5301287:C:CC | acceptor_gain | 0.4800 |
| 11:5301737:C:A | donor_gain | 0.4600 |
| 11:5301463:A:T | acceptor_gain | 0.4400 |
| 11:5301612:AAGAT:A | donor_gain | 0.4400 |
| 11:5301613:AGATA:A | donor_gain | 0.4400 |
AlphaMissense
2047 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:5301422:A:C | F175L | 0.785 |
| 11:5301422:A:T | F175L | 0.785 |
| 11:5301424:A:G | F175L | 0.785 |
| 11:5301917:G:C | F10L | 0.732 |
| 11:5301917:G:T | F10L | 0.732 |
| 11:5301919:A:G | F10L | 0.732 |
| 11:5301647:G:C | F100L | 0.695 |
| 11:5301647:G:T | F100L | 0.695 |
| 11:5301649:A:G | F100L | 0.695 |
| 11:5301203:A:C | F248L | 0.685 |
| 11:5301203:A:T | F248L | 0.685 |
| 11:5301205:A:G | F248L | 0.685 |
| 11:5301164:A:C | F261L | 0.674 |
| 11:5301164:A:T | F261L | 0.674 |
| 11:5301166:A:G | F261L | 0.674 |
| 11:5301659:G:C | F96L | 0.671 |
| 11:5301659:G:T | F96L | 0.671 |
| 11:5301661:A:G | F96L | 0.671 |
| 11:5301902:G:C | F15L | 0.622 |
| 11:5301902:G:T | F15L | 0.622 |
| 11:5301904:A:G | F15L | 0.622 |
| 11:5301587:G:C | F120L | 0.612 |
| 11:5301587:G:T | F120L | 0.612 |
| 11:5301589:A:G | F120L | 0.612 |
| 11:5301374:A:C | F191L | 0.570 |
| 11:5301374:A:T | F191L | 0.570 |
| 11:5301376:A:G | F191L | 0.570 |
dbSNP variants (sampled 300 via entrez): RS1006751164 (11:5300708 T>C), RS1006860024 (11:5302172 T>C), RS1006874857 (11:5302871 G>A), RS1006890898 (11:5302353 G>A,C), RS1007878587 (11:5300872 G>A,T), RS1010317605 (11:5302612 A>G,T), RS1011210955 (11:5303192 C>G,T), RS1011240092 (11:5303403 A>C), RS1012739128 (11:5302955 T>C), RS1014292640 (11:5303515 T>G), RS1015746610 (11:5303460 T>C), RS1016751780 (11:5302438 G>T), RS1017201895 (11:5303231 T>C), RS1018252220 (11:5302179 T>C), RS1018721516 (11:5302883 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007006_9 | Logical memory (delayed recall) in normal cognition | 1.000000e-07 |
| GCST007060_4 | Response to SSRI (symptom remission) | 4.000000e-07 |
| GCST007061_10 | Response to antidepressants (symptom remission) | 2.000000e-07 |
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004874 | memory performance |
| EFO:0005658 | response to selective serotonin reuptake inhibitor |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 3,19-(2-bromobenzylidene)andrographolide | decreases response to substance, increases expression | 1 |
| kojic acid | decreases expression | 1 |
| ICG 001 | decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | decreases expression | 1 |
| Air Pollutants | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.